Ferric carboxymaltose.

Hosp Pharm

Director, Drug Information Center, and Professor of Pharmacy Practice, College of Pharmacy, Washington State University Spokane, PO Box 1495, Spokane, Washington 99210-1495. The authors indicate no relationships that could be perceived as a conflict of interest .

Published: January 2014

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The January 2014 monograph topics are obinutuzumab, anti-inhibitor coagulant complex, macitentan, riociguat, and conjugated estrogens/bazedoxifene. The DUE/MUE is on conjugated estrogens/bazedoxifene.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887599PMC
http://dx.doi.org/10.1310/hpj4901-52DOI Listing

Publication Analysis

Top Keywords

formulary monograph
12
monograph service
12
conjugated estrogens/bazedoxifene
8
formulary
5
monographs
5
ferric carboxymaltose
4
carboxymaltose month
4
month subscribers
4
subscribers formulary
4
monograph
4

Similar Publications

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services.

View Article and Find Full Text PDF

Resmetirom.

Hosp Pharm

September 2024

College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services.

View Article and Find Full Text PDF

Cefepime/Enmetazobactam.

Hosp Pharm

December 2024

Drug Information Center, and Regents Professor in Pharmacy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services.

View Article and Find Full Text PDF

Lacosamide in palliative medicine: a retrospective chart review.

BMJ Support Palliat Care

October 2024

Earl Mountbatten Hospice, Newport, UK.

Objectives: To investigate the efficacy and safety of oral (PO) and subcutaneous (SC) lacosamide for refractory symptoms in the palliative setting.

Methods: We conducted a retrospective chart review of the use of lacosamide since it was introduced in our palliative care service 1½ years ago. All clinical notes, medication administration records and infusion monitoring documentation were examined to ascertain therapeutic aim, efficacy, and tolerability.

View Article and Find Full Text PDF

Capivasertib.

Hosp Pharm

October 2024

Drug Information Center, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

Article Synopsis
  • Subscribers receive 5 to 6 detailed monographs monthly on new drugs or those in late-stage clinical trials, aimed at Pharmacy and Therapeutics Committees.
  • Each month includes a 1-page summary of helpful medications for meetings and training sessions in pharmacy and nursing.
  • A comprehensive drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided, with online access to monographs and customization options for facilities.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!